Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics
Year: 2012
Type: review
Abstract: Selected reaction monitoring (SRM) - also known as multiple reaction monitoring (MRM) - has emerged as a promising high-throughput targeted protein quantification technology for candidate biomarker verification and systems biology applications. A major bottleneck for current SRM technology, however, is insufficient sensitivity for, e.g. detecting low-abundance biomarkers likely present at the low ng/mL to pg/mL range in human blood plasma or serum, or extremely low-abundance signaling proteins in cells or tissues. Herein, we review recent advances in methods and technologies, including front-end immunoaffinity depletion, fractionation, selective enrichment of target proteins/peptides including posttranslational modifications, as well as advances in MS instrumentation which have significantly enhanced the overall sensitivity of SRM assays and enabled the detection of low-abundance proteins at low- to sub-ng/mL level in human blood plasma or serum. General perspectives on the potential of achieving sufficient sensitivity for detection of pg/mL level proteins in plasma are also discussed.
Source: PROTEOMICS
Language: English
Subfield: Spectroscopy
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
Awards: Transplant injury biology and monitoring by urine proteomics, The Early Detection Research Network: Biomarker Developmental Laboratories, A Proteomics Research Resource for Integrative Biology, A Research Resource for Ultra-sensitive High Throughput Proteomics, Urinary Proteome Monitoring for Transplant Injury, G6839162810, Center for Application of Advanced Clinical Proteomic Technologies for Cancer, A Universal Multiplex Assay System for High-Throughput Clinical Applications
OpenAlex ID: W2065839570
